All market verdicts

CRSP UP market verdict | Ezbrisk

Published: 1785871223506

Anomaly score: 1.598975180702553

Confidence: 0.75

Market summary

CRSP earnings beat fades

Ezbrisk assessment

The stock is climbing slightly after a violent morning spike on Q2 earnings, now settling into low volatility as the initial reaction cools and volume normalizes.

Sources: https://www.gurufocus.com/news/crispr-therapeutics-crsp-q2-earnings-beat-highlights-growth-despite-unprofitability, https://www.biospace.com/press-releases/crispr-therapeutics-provides-business-update-and-reports-second-quarter-2026-financial-results, https://robinhood.com/us/en/stocks/CRSP/, https://ir.crisprtx.com/news-releases/news-release-details/crispr-therapeutics-provides-business-update-and-reports-15/, https://finance.yahoo.com/quote/CRSP/

Verdict ID: 9b420506-3c7a-42ca-9cd1-8bce93ad88de